Published:
7:35 AM April 2, 2021
Suffolk firm PBD Biotech has secured £2.3m of funding to gain international validation for its new diagnostic test for bovine tuberculosis in cattle
- Credit: Ian Burt
An East Anglian firm s game-changing test for a devastating cattle disease has won £2.3m of funding to help it secure international validation.
PBD Biotech, based at Thurston, near Bury St Edmunds, has developed a rapid, accurate test for bovine tuberculosis (bTB) that it claims could enable farmers to effectively remove the disease from their herds.
The new investment will enable the company to take its patented Actiphage test through to validation by the World Organisation for Animal Health (OIE).
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
People moves: StepStone appoints Europe MD; Batho joins Stenprop [updated] ipe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ipe.com Daily Mail and Mail on Sunday newspapers.
Dreams come true because of CPEC thenews.com.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenews.com.pk Daily Mail and Mail on Sunday newspapers.